Pressure to adopt “sensitive but unclassified” control markings on information that does not qualify for classification is growing, along with opposition to such controls, among some academic researchers who study terrorism-related topics. See “Scientific Openness: Should Academics Self-Censor Their Findings on Terrorism?” by Yudhijit Bhattacharjee, Science, May 19.
“The secrecy that has become such a hallmark of the Bush administration did not begin with Sept. 11, as the White House often suggests. It began in the earliest days of January 2001, as the administration was taking shape,” according to a National Public Radio account. See “From the Start, Bush White House Kept Secrets” by Don Gonyea, NPR Weekend Edition, May 21.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.